Long-Term Response of Obstructive Hypertrophic Cardiomyopathy Patients to Mavacamten Based on Sex

IF 10.3 1区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

JACC. Heart failure Pub Date : 2025-06-01 DOI:10.1016/j.jchf.2025.02.005

Milind Y. Desai MD, MBA , Sara Saberi MD, MS , Jeffrey B. Geske MD , Andrew Wang MD , Paul Cremer MD, MS , David R. Fermin MD , Mark A. Zenker MD , Neal K. Lakdawala MD , Albree Tower-Rader MD , Srihari S. Naidu MD , Kathy Lampl MD , Anjali Owens MD , the VALOR-HCM Investigators

引用次数: 0

查看原文本刊更多论文

基于性别的阻塞性肥厚性心肌病患者对马伐卡坦的长期反应：来自VALOR-HCM试验的见解

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

JACC. Heart failure CARDIAC & CARDIOVASCULAR SYSTEMS-

CiteScore

21.20

自引率

2.30%

发文量

164

期刊介绍： JACC: Heart Failure publishes crucial findings on the pathophysiology, diagnosis, treatment, and care of heart failure patients. The goal is to enhance understanding through timely scientific communication on disease, clinical trials, outcomes, and therapeutic advances. The Journal fosters interdisciplinary connections with neuroscience, pulmonary medicine, nephrology, electrophysiology, and surgery related to heart failure. It also covers articles on pharmacogenetics, biomarkers, and metabolomics.